Asaf Alperovitz

With a career spanning over three decades, Mr. Alperovitz brings extensive expertise and leadership experience across multiple industries. Most recently, from 2019 to 2024, Mr. Alperovitz served as the CFO of Delta Galil, a global high-tech apparel company. Prior to Delta Galil, he held CEO and CFO positions at NASDAQ, NYSE and TASE listed companies, including Syneron Medical, Omrix Pharmaceuticals (acquired by J&J), Tefron and Allmed Solutions. He also previously held senior management roles at Ernst & Young. Throughout his career, Mr. Alperovitz has led multiple IPOs, secondary offerings, M&A deals, and strategic transformations. He holds a BA in Accounting & Economics and an MBA from Tel-Aviv University.